Placebo IV + SAD IV Dose 1 - 150mg ABS201 IV Single Dose for alopecia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 3 Dec 2025: Trial started, NCT07317544
  2. 5 Jan 2026: Trial registered, NCT07317544

The trials

NCT07317544: Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Adults With and Without Androgenetic Alopecia

State
Under way
Phase
Phase 1 and Phase 2
People
227 planned
Started
3 Dec 2025
Primary completion
Jul 2028
Arms
SAD IV Dose 1 - 150mg ABS201 or Placebo, SAD IV Dose 2 - 450mg ABS201 or Placebo, SAD IV Dose 3 - 900mg ABS201 or Placebo, SAD IV Dose 4 - 1800mg ABS201 or Placebo
Results
None posted
  1. 3 Dec 2025: Trial started
  2. 5 Jan 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.